Latest News

OPKO Health (OPK) has drawn fresh attention after recent share price moves, with the stock last closing at $1.46. For investors, the focus now shifts to how its pharmaceuticals and diagnostics businesses support that valuation. See our latest analysis for OPKO Health. The recent 1 month share price return of 14.96% and 90 day share price return of 22.69% suggest momentum is building for OPKO Health. However, the 5 year total shareholder return of 64.22% and 3 year total shareholder return of...

Gap Inc. recently outlined a major AI-driven overhaul of its marketing operations, partnering with Zeta Global, Google Cloud and Publicis Sapient to build real-time, personalized customer engagement on unified data platforms. An interesting angle is how Gap’s leadership frames AI as a tool to free marketers for more creative work while supporting longer-term brand loyalty and its broader sustainability-focused repositioning. We’ll now examine how this AI-powered personalization push shapes...

Iluka Resources has in recent days secured its first rare earths offtake agreement for its Eneabba refinery with a global automotive company, locking in at least US$155 million in take-or-pay revenue and incorporating protections against extreme price swings as construction of the Western Australian facility advances. This agreement not only underpins Eneabba’s economics but also reinforces Iluka’s role in building Australia’s onshore critical minerals processing capacity and reducing...

South32 (ASX:S32) has been back in focus after reporting H1 FY2026 results with higher underlying earnings and profit, while progressing its Hermosa critical minerals project and addressing rail constraints at its South Africa Manganese operations. See our latest analysis for South32. At a recent share price of A$4.14, South32’s 7 day share price return is down 3.0% and the 30 day share price return is down 4.8%. However, the year to date share price return of 16.6% and 1 year total...

Renewable energy equipment and services stocks are caught between political uncertainty and a potential policy push. Slower adoption of heat pumps and electric vehicles in the UK hints at possible stagnation in demand. At the same time, a £15b government plan for grants and loans, along with calls to make electricity cheaper, could redirect support toward electrification and clean energy infrastructure. For investors weighing how these crosscurrents might affect portfolios, this article walks...

Acadia Healthcare recently expanded its behavioral health footprint through new facilities and partnerships, aiming to increase treatment capacity amid rising mental health needs in the United States. This expansion push underscores how the company is trying to align its network more closely with policy support and insurer demand for behavioral health services. Next, we’ll examine how this facility expansion and partnership activity could influence Acadia Healthcare’s existing investment...

In June 2026, Tootsie Roll Industries rolled out a new animated TV spot featuring Mr. Owl and a color-changing chameleon, highlighting the chewy variety of Tootsie Roll flavors and extending the refreshed “How Many Licks” campaign across connected TV, YouTube, and major social media platforms. The ad marks a meaningful shift in brand storytelling as Mr. Owl enjoys a Tootsie Roll instead of a Tootsie Pop, tying nostalgia to recent product efforts like “The Berry Ones” at select Walmart stores...

Why the CMB.TECH shipping deal matters for Fortescue stock Fortescue (ASX:FMG) has drawn investor attention after agreeing with CMB.TECH NV to charter up to 12 ammonia-capable Newcastlemax vessels, aimed at lowering shipping emissions and supporting ammonia fuel adoption. See our latest analysis for Fortescue. Despite the CMB.TECH agreement highlighting Fortescue’s push into lower carbon shipping, recent momentum has softened, with the share price down 10.37% over the past month and 12.96%...

On June 15, 2026, Perseus Mining announced it had increased its equity buyback authorization by A$50 million to A$150 million in total. This larger buyback program highlights management’s willingness to commit additional capital to repurchasing shares, which can influence how investors view capital allocation discipline. Next, we’ll examine how this expanded A$150 million buyback authorization may reshape Perseus Mining’s existing investment narrative and risk-reward profile. Rare earth...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

The new Quest-compatible system strengthens the consumer thesis, but investors will be watching conversion closely.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Recent updates show Pathward Financial, a banking-as-a-service and commercial finance provider, maintaining robust financial health with year-over-year growth in both revenue and net profit, alongside very high institutional ownership that recently eased slightly from earlier levels. Despite relatively low operating efficiency, the company’s strong net interest income profile, best-in-class net interest margin, and EPS-accretive share repurchase program highlight how its banking-as-a-service...

Sandoz Group AG has opened a fully digitally integrated, US$99 million biosimilar development centre in Ljubljana, Slovenia, spanning about 10,000 m² and employing more than 200 scientists as part of its plan to build an end-to-end European biosimilar hub. The facility’s integration with sites in Germany, the UK, Slovenia and the recently acquired Toulouse, France, biosimilar plant highlights Sandoz’s push to bring more biosimilar development and manufacturing in-house across its European...

Option Care Health (OPCH) is back on investors’ radar after quarterly revenue and full year guidance came in below analyst expectations, with biosimilar pressure weighing on high margin chronic inflammatory disease infusion volumes. See our latest analysis for Option Care Health. Against this backdrop, Option Care Health’s short term share price performance has been relatively resilient, with a 1 day share price return of 3.15% and 30 day share price return of 4.97%. However, the 90 day share...

Affiliated Managers Group (AMG) has drawn fresh attention after reporting quarterly revenue growth of 8.50% and a 52.49% rise in net profit, alongside technical indicators that currently point to bullish price momentum. See our latest analysis for Affiliated Managers Group. Despite a small pullback over the past week, Affiliated Managers Group’s recent 30-day share price return of 15.98% and 90-day share price return of 24.78% point to building momentum on top of a 1-year total shareholder...

The Dallas Fed’s research on oil shock resilience suggests U.S. markets may now react very differently to the kind of supply disruption that once rattled portfolios. With oil expenditures at roughly 3% of GDP and the U.S. positioned as a net exporter, companies tied to domestic energy advantages can see their risk profile change when global supply is strained. This article looks at three U.S. Oil Resilience Stocks Leveraging Domestic Energy Advantages that are closely exposed to this theme,...

Dyne Therapeutics recently expanded its senior secured loan facility with Hercules Capital to as much as US$400.00 million and, on June 22, 2026, appointed veteran biotech executive Barry E. Greene as an independent Class I director. Together, the enlarged non-dilutive debt capacity and Greene’s commercialization background suggest Dyne is actively building the financial and leadership infrastructure needed for a potential shift from pure clinical development toward product launches. Next,...

Flow Traders (ENXTAM:FLOW) has laid out its Horizon 2030 roadmap, targeting a role as a 24/7 liquidity provider across traditional and digital assets, underpinned by AI, deep learning, and expanded ETF and crypto activities. See our latest analysis for Flow Traders. At a share price of €26.22, Flow Traders has seen short term share price pressure, with a 1 month share price return down 12.83%, yet its 3 year total shareholder return is up 32.40%. This suggests that momentum has cooled...

NNN REIT, Inc. recently exercised a US$200 million incremental term loan option, expanding its senior unsecured term loan facility to US$500 million maturing in 2029, while also amending term loan and revolver pricing grids to slightly reduce SOFR-based borrowing margins. By layering in a US$100 million forward starting swap to lock SOFR and modestly lowering its credit facility spreads, NNN REIT is fine‑tuning its funding costs and interest rate profile in a way that could matter for...

WaFd (WAFD) is drawing investor attention after recent share price moves, with the stock last closing at $37.26. The question now is how that price lines up with its fundamentals. See our latest analysis for WaFd. WaFd's recent 18.10% 3 month share price return and 15.97% year to date share price return sit alongside a 32.48% 1 year total shareholder return, indicating positive momentum that investors are weighing against the current valuation. If WaFd's recent gains have you thinking about...

Heineken (ENXTAM:HEIA) is back in focus after the board selected Rafael Oliveira, formerly CEO of JDE Peet's, to take over as chief executive as the brewer works through softer demand and falling beer volumes. See our latest analysis for Heineken. Heineken’s 1 day share price return of 2.2% to €72.56 builds on a 90 day share price return of 10%, even though the 1 year total shareholder return declined 1.3% and the 5 year total shareholder return declined 21.9%. This hints that short term...

Recent share performance and business profile First Financial Bancorp (FFBC) has attracted attention after a period of steady share price moves, with the stock recently closing at $32.47 and recording positive total returns over the past year and past 3 months. The Cincinnati based regional bank operates through First Financial Bank. It focuses on community banking services for individuals and businesses across Ohio, Indiana, Kentucky, and Illinois, including deposits, loans, and various...

Neogen (NEOG) is back in focus after expanding FIFRA Section 2(ee) recommendations for its Prozap insect control products in Texas and Florida, which gives livestock producers new options in New World Screwworm response efforts. See our latest analysis for Neogen. Despite the product update, Neogen’s recent share price momentum has softened, with the stock at US$8.83 and short term share price returns weaker, while the 1 year total shareholder return of 79.11% contrasts with deeper 3 and 5...